Follow
Andrew Bate
Title
Cited by
Cited by
Year
A Bayesian neural network method for adverse drug reaction signal generation
A Bate, M Lindquist, IR Edwards, S Olsson, R Orre, A Lansner, ...
European journal of clinical pharmacology 54, 315-321, 1998
13461998
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
EP van Puijenbroek, A Bate, HGM Leufkens, M Lindquist, R Orre, ...
Pharmacoepidemiology and drug safety 11 (1), 3-10, 2002
12042002
Quantitative signal detection using spontaneous ADR reporting
A Bate, SJW Evans
Pharmacoepidemiology and drug safety 18 (6), 427-436, 2009
8172009
Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis
EJ Sanz, C De-las-Cuevas, A Kiuru, A Bate, R Edwards
The Lancet 365 (9458), 482-487, 2005
4882005
Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study
DM Coulter, A Bate, RHB Meyboom, M Lindquist, IR Edwards
Bmj 322 (7296), 1207-1209, 2001
3832001
Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery
GN Norén, J Hopstadius, A Bate
Statistical methods in medical research 22 (1), 57-69, 2013
2832013
A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database
M Lindquist, M Stĺhl, A Bate, IR Edwards, RHB Meyboom
Drug safety 23, 533-542, 2000
2512000
Reporting to improve reproducibility and facilitate validity assessment for healthcare database studies V1. 0
IISTFRWEHCDM S. V. Wang, S. Schneeweiss
Pharmacoepidemiology and Drug Safety 26 (9), 1018-1032, 2017
226*2017
Temporal pattern discovery in longitudinal electronic patient records
GN Norén, J Hopstadius, A Bate, K Star, IR Edwards
Data Mining and Knowledge Discovery 20, 361-387, 2010
2152010
Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events
GN Norén, A Bate, R Orre, IR Edwards
Statistics in medicine 25 (21), 3740-3757, 2006
2042006
A statistical methodology for drug–drug interaction surveillance
GN Norén, R Sundberg, A Bate, IR Edwards
Statistics in medicine 27 (16), 3057-3070, 2008
1942008
A data mining approach for signal detection and analysis
A Bate, M Lindquist, IR Edwards, R Orre
Drug safety 25, 393-397, 2002
1942002
Decision support methods for the detection of adverse events in post-marketing data
M Hauben, A Bate
Drug discovery today 14 (7-8), 343-357, 2009
1822009
Myocarditis related to clozapine treatment
S Hägg, O Spigset, AB BAHons, TG Söderström
Journal of clinical psychopharmacology 21 (4), 382, 2001
1752001
Bayesian neural networks with confidence estimations applied to data mining
R Orre, A Lansner, A Bate, M Lindquist
Computational Statistics & Data Analysis 34 (4), 473-493, 2000
1562000
Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross‐national descriptive study from the PROTECT‐EU …
C Huerta, V Abbing‐Karahagopian, G Requena, B Oliva, Y Alvarez, ...
Pharmacoepidemiology and drug safety 25, 56-65, 2016
1512016
Good signal detection practices: evidence from IMI PROTECT
AFZ Wisniewski, A Bate, C Bousquet, A Brueckner, G Candore, K Juhlin, ...
Drug safety 39, 469-490, 2016
1492016
Duplicate detection in adverse drug reaction surveillance
GN Norén, R Orre, A Bate, IR Edwards
Data Mining and Knowledge Discovery 14, 305-328, 2007
1462007
Disproportionality methods for pharmacovigilance in longitudinal observational databases
I Zorych, D Madigan, P Ryan, A Bate
Statistical methods in medical research 22 (1), 39-56, 2013
1332013
From association to alert—a revised approach to international signal analysis
M Lindquist, IR Edwards, A Bate, H Fucik, AM Nunes, M Stĺhl
Pharmacoepidemiology and drug safety 8 (S1), S15-S25, 1999
1171999
The system can't perform the operation now. Try again later.
Articles 1–20